Generic Name and Formulations:
Fluorescein (as sodium) 100mg/mL (10%); soln for IV inj; preservative-free.
Alcon Laboratories, Inc.
Indications for FLUORESCITE:
Diagnostic angiography or angioscopy of the retina and iris vasculature.
Give by IV inj rapidly into the antecubital vein (normally 1mL/sec). 500mg (5mL). Highly sensitive imaging system (eg, scanning laser ophthalmoscope): reduce dose to 2mL.
Give by IV inj rapidly into the antecubital vein (normally 1mL/sec). 7.7mg/kg; max 500mg (5mL).
History of allergy. Bronchial asthma. Avoid extravasation; severe local tissue damage can result. Pregnancy. Nursing mothers: discontinue for ≥4 days after inj (pump and discard the milk during this period).
Skin and urine discoloration, nausea, vomiting, GI distress, hypersensitivity reactions, headache, thrombophlebitis; rare: cardiopulmonary reactions, convulsions, syncope.
Single use vial (5mL)—1
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- Posttraumatic Stress Disorder Associated With Reduced Brain Volume
- First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide
- ADHD Medications Compared for Efficacy, Tolerability in Children and Adults
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation